Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

The following is a summary of “Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque ...

Discover a recent study that has investigated the efficacy of excimer light and topical methotrexate 1% hydrogel in managing ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

Bimzelx was approved for the treatment of moderate or severe plaque psoriasis. If you have psoriasis under your arms, aka inverse psoriasis, you might wonder if it’s OK to use deodorant or ...

and vitamin treatments, homeopathy, non-prescription tanning, and other non-traditional modalities (Fleischer et al., 1996). The CAM-using group had greater psoriasis severity, but did not ...

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...

a dose was added which essentially called for two additional doses of the drug over the first week of treatment. This change greatly accelerated the improvement seen in psoriasis versus the previous ...

Improved Psoriasis Area and Severity Index scores and decreased rates of adverse events, serious adverse events, and discontinuations were observed through 3 years of continuous deucravacitinib ...

The "Plaque Psoriasis Market by Treatment, by Route of Administration, by End-user, and by Region" report has been added to ...